Literature DB >> 8907377

Corneal endothelium in mucopolysaccharide storage disorders. Morphologic studies in animal models.

R J Mollard1, P Telegan, M Haskins, G Aguirre.   

Abstract

In the systemic mucopolysaccharidoses (MPS) in animals, corneal clouding resulted from storage of glycosaminoglycans (GAG) in stromal keratocytes. The corneal epithelium was normal (MPS VI and VII) or minimally affected (MPS I), and stromal edema was not a feature even though the corneal endothelium demonstrated variable pathology. The MPS I (cat) cornea showed endothelial cells with large numbers of secondary lysosomal inclusions that were vacuolated or had a granular matrix. The endothelium was uniformly affected, but was not markedly hypertrophied. In contrast, the MPS VI (cat) cornea showed no endothelial cell disease. The MPS VII (dog) cornea had the most significant and dramatic endothelial pathology. The cells were massively hypertrophied and contained large numbers of vacuolated lysosomal inclusions. Regardless of the severity of the morphologic disease, the endothelial cells in these animal models functioned normally in maintaining the relative dehydration of the cornea. The corneal clouding was the result of storage in stromal keratocytes rather than corneal edema from endothelial dysfunction.

Entities:  

Mesh:

Year:  1996        PMID: 8907377

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Novel AAV serotypes for improved ocular gene transfer.

Authors:  Corinna Lebherz; Albert Maguire; Waixing Tang; Jean Bennett; James M Wilson
Journal:  J Gene Med       Date:  2008-04       Impact factor: 4.565

2.  Clinical and morphological features including expression of betaig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea.

Authors:  Saeed Akhtar; Andrew Tullo; Bruce Caterson; Janet R Davies; Kelly Bennett; Keith M Meek
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

3.  Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs.

Authors:  Katherine Parker Ponder; John R Melniczek; Lingfei Xu; Margaret A Weil; Thomas M O'Malley; Patricia A O'Donnell; Van W Knox; Gustavo D Aguirre; Hamutal Mazrier; N Matthew Ellinwood; Meg Sleeper; Albert M Maguire; Susan W Volk; Robert L Mango; Jean Zweigle; John H Wolfe; Mark E Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

4.  Bone marrow transplantation for feline mucopolysaccharidosis I.

Authors:  N Matthew Ellinwood; Marie-Anne Colle; Margaret A Weil; Margret L Casal; Charles H Vite; Staci Wiemelt; Christopher W Hasson; Thomas M O'Malley; Xingxuan He; Ulana Prociuk; Lucie Verot; John R Melniczek; Anne Lannon; Gustavo D Aguirre; Van W Knox; Sydney M Evans; Marie T Vanier; Edward H Schuchman; Steven U Walkley; Mark E Haskins
Journal:  Mol Genet Metab       Date:  2007-05-07       Impact factor: 4.797

5.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

Review 6.  Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.

Authors:  Carlton R Fenzl; Kyla Teramoto; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2015-09-07

Review 7.  Mucopolysaccharidosis: A broad review.

Authors:  Ritu Nagpal; Ram Bharos Goyal; K Priyadarshini; Seema Kashyap; Mohita Sharma; Rajesh Sinha; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.